Creamer Victoria L's Form 4 filing
Charles River Laboratories International, Inc. (CRL) · filed Aug 17, 2021
- Accession no.
- 0001127602-21-023848
- Filed
- Aug 17, 2021
- Trade date
- Aug 16, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $2.87M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Creamer Victoria LCIK 0001632780 | Officer (EVP & Chief People Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2021 | Common Stock | MOption exerciseAcquired | +2,145 | $124.13 | +$266,258.85 | 8,531 | Direct | |
| Aug 16, 2021 | Common Stock | MOption exerciseAcquired | +3,380 | $144.67 | +$488,984.6 | 11,911 | Direct | |
| Aug 16, 2021 | Common Stock | MOption exerciseAcquired | +1,392 | $179.66 | +$250,086.72 | 13,303 | Direct | |
| Aug 16, 2021 | Common Stock | SSaleDisposed | −6,917 | $415.24F1 | −$2,872,215.08 | 6,386 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2021 | Common Stock | MOption exerciseDisposed | −2,145 | $0.00 | $0 | 2,145 | Direct | |
| Aug 16, 2021 | Common Stock | MOption exerciseDisposed | −3,380 | $0.00 | $0 | 3,381 | Direct | |
| Aug 16, 2021 | Common Stock | MOption exerciseDisposed | −1,392 | $0.00 | $0 | 4,179 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was executed in multiple trades at prices ranging from $415 to $415.92. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.